• Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress

    9 September 2024
    Download

  • ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer

    9 September 2024
    Download

  • Ergebnisse klinischer Studien Haupttreiber der Kursentwicklung

    19 August 2024
    Download

  • SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers

    8 August 2024
    Download

  • Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-01, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-01, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Pso

    29 July 2024
    Download

  • Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer

    24 July 2024
    Download

  • Genalyte - FDA Clears Silicon Chip Based Blood Test

    22 July 2024
    Download

  • Das A und O beim Investieren in Biotech

    18 July 2024
    Download

  • Johnson & Johnson strengthens pipeline to lead in atopic dermatitis with acquisition of Yellow Jersey Therapeutics

    11 July 2024
    Download

  • SWIXX BioPharma formally closes the deal with Biopas, expanding to Latin America

    4 July 2024
    Download

  • Alumis Announces Pricing of Initial Public Offering

    27 June 2024
    Download

  • Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160

    27 June 2024
    Download

  • Swiss growth rocket Swixx

    26 June 2024
    Download

  • Schweizer Wachstumsrakete Swixx

    26 June 2024
    Download

  • Innovationen treiben Durchbrüche im gesamten Biotech-Sektor voran

    19 June 2024
    Download

  • Schweizer HBM-Beteiligung gelingt Mega-Deal

    5 June 2024
    Download

  • Transaktion HBM-Portfoliounternehmen Yellow Jersey geht an Johnson & Johnson

    28 May 2024
    Download

  • Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-specific Antibody for the Treatment of Atopic Dermatitis

    28 May 2024
    Download

  • Swixx BioPharma Expands to Latin America Through a Strategic Acquisition and Combination with Biopas

    22 May 2024
    Download

  • Healthcare-Investments: Biotech gewinnt Anteile von Big Pharma-Unternehmen

    21 May 2024
    Download

  • Welche Unternehmen Novo Nordisk und Eli Lilly auf die Pelle rücken

    19 May 2024
    Download

  • Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline

    9 May 2024
    Download

  • Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis

    2 May 2024
    Download

  • Biotech: Midcap-Werte als spannender Investment Case

    17 April 2024
    Download

  • NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression

    15 April 2024
    Download
    • More news